US Stock MarketDetailed Quotes

MCRB Seres Therapeutics

Watchlist
  • 0.880
  • -0.005-0.59%
Close Aug 16 16:00 ET
  • 0.875
  • -0.005-0.53%
Post 20:02 ET
133.49MMarket Cap-739P/E (TTM)

Seres Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Seres Therapeutics Q2 2024 Earnings Date

Currency：USDAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
-100.00%
-100.00%
--
EPS
-0.28
-0.22
+0.06
Beat Est.
-178.81%
-161.11%
+22.45%
Analyst Rating
Strong Buy

Aug 18, 2024

Seres Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 22.143M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--
Mar 5, 20242023/Q464.000K / -180.830K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 22.143M--
Aug 13, 20242024/Q20.000 / 0.000--
May 8, 20242024/Q10.000 / 250.000K--
Mar 5, 20242023/Q464.000K / -180.830K--

Unlock Free Earnings Estimates

Seres Therapeutics Earnings Reports

  • Seres Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 10:42 ET

  • Seres Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 8 10:03 ET

  • Seres Therapeutics | 10-K: FY2023 Annual Report

    Mar 5 10:02 ET

  • Seres Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 10:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 18, 2024

    Strong Buy

    • Buy

      75.00%

    • Hold

      25.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg